Can we prevent diabetic ketoacidosis in children?

Pediatric Diabetes

Volumn 8, Issue SUPPL. 6, 2007, Pages 24-33

  Bismuth, Elise ^a   Laffel, Lori ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

3 OHB; DKA; Management; Sick day; T1D

Indexed keywords

GLUCOSE; INSULIN; KETONE;

AWARENESS; CHILD; CLINICAL PROTOCOL; CONTINUOUS INFUSION; DEATH; DIABETIC KETOACIDOSIS; FAMILY HISTORY; FLUID THERAPY; GENETIC SUSCEPTIBILITY; GLUCOSE BLOOD LEVEL; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MONITORING; MORBIDITY; OUTPATIENT; PATIENT CARE; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; SECONDARY PREVENTION; SELF CARE; SELF MONITORING; SYMPTOM; UNITED STATES; URINALYSIS;

CHILD; DIABETIC KETOACIDOSIS; HUMANS; KETONES; RISK FACTORS;

EID: 34548260044     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2007.00292.x     Document Type: Review

References (58)

1. Maldonado MR, Chong ER, Oehl MA, B alasubramanyam A. Economic impact of diabetic ketoacidosis in a multiethnic indigent population: Analysis of costs based on the precipitating cause. Diabetes Care 2003: 26: 1265-1269.
2. Fishbein H, Palumbo P. Acute metabolic complications in diabetes. In: Harris MI, Cowie CC, Stern MP, Boyco EJ, Reiber GE, Bennett PH, eds. Diabetes in America. Bethesda, MD: NIH/NIDDK; 1995: 283-292.
3. Kaufman FR, Halvorson M. The treatment and prevention of diabetic ketoacidosis in children and adolescents with type I diabetes mellitus. Pediatr Ann 1999: 28: 576-582.
4. Curtis JR, To T, Muirhead S, C ummings E, D aneman D. Recent trends in hospitalization for diabetic ketoacidosis in ontario children. Diabetes Care 2002: 25: 1591-1596.
5. Scibilia J, Finegold D, Dorman J, Becker D, Drash A. Why do children with diabetes die? Acta Endocrinol Suppl (Copenh) 1986: 279: 326-333.
6. Edge JA, Ford-Adams ME, Dunger DB. Causes of death in children with insulin dependent diabetes 1990-96. Arch Dis Child 1999: 81: 318-323.
7. Glaser N, Barnett P, Mccaslin I et al. Risk factors for cerebral edema in children with diabetic ketoacidosis. The Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics. N Engl J Med 2001: 344: 264-269.
8. Wolfsdorf J, Glaser N, Sperling MA. Diabetic ketoacidosis in infants, children, and adolescents: A consensus statement from the American Diabetes Association. Diabetes Care 2006: 29: 1150-1159.
9. Tunbridge W. Deaths due to diabetic ketoacidosis. Q J Med 1981: 50: 502-504.
10. Basu A, Close CF, Jenkins D, Krentz AJ, Nattrass M, Wright AD. Persisting mortality in diabetic ketoacidosis. Diabet Med 1993: 10: 282-284.
11. Dunger DB, Sperling MA, Acerini CL et al. European Society for Paediatric Endocrinology/Lawson Wilkins Pediatric Endocrine Society consensus statement on diabetic ketoacidosis in children and Eadolescents. Pediatrics 2004: 113: e133-e140.
12. Levy-Marchal C, Patterson CC, Green A. Geographical variation of presentation at diagnosis of type I diabetes in children: The EURODIAB study. European and Diabetes. Diabetologia 2001: 44 (Suppl. 3): B75-B80.
13. Bui TP, Werther GA, C ameron FJ. Trends in diabetic ketoacidosis in childhood and adolescence: A 15-yr experience. Pediatr Diabetes 2002: 3: 82-88.
14. Smith CP, Firth D, Bennett S, Howard C, Chisholm P. Ketoacidosis occurring in newly diagnosed and established diabetic children. Acta Paediatr 1998: 87: 537-541.
15. Pinkey JH, Bingley PJ, Sawtell PA, Dunger DB, Gale EA. Presentation and progress of childhood diabetes mellitus: A prospective population-based study. The Bart's-Oxford Study Group. Diabetologia 1994: 37: 70-74.
16. Rewers A, Klingensmith G, Davis C et al. Diabetic ketoacidosis at onset of diabetes: The SEARCH for Diabetes in Youth Study (Abstract). Diabetes 2005: 54 (Suppl. 1): A63.
17. Quinn M, Fleischman A, Rosner B, Nigrin DJ, Wolfsdorf JI. Characteristics at diagnosis of type 1 diabetes in children younger than 6 years. J Pediatr 2006: 148: 366-371.
18. Komulainen J, Kulmala P, Savola K et al. Clinical, autoimmune, and genetic characteristics of very young children with type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes Care 1999: 22: 1950-1955.
19. DIAMOND Project Group. Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999. Diabet Med 2006: 23: 857-866.
20. Green A, Patterson CC. Trends in the incidence of childhood-onset diabetes in Europe 1989-1998. Diabetologia 2001: 44 (Suppl. 3): B3-B8.
21. Diabetes Control and Complications Trial R esearch Group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: J Pediatr 1994: 125: 177-188.
22. Rewers A, Chase HP, Mackenzie T et al. Predictors of acute complications in children with type 1 diabetes. JAMA 2002: 287: 2511-2518.
23. Kovacs M, Charron-Prochownik D, Obrosky DS. A longitudinal study of biomedical and psychosocial predictors of multiple hospitalizations among young people with insulin-dependent diabetes mellitus. Diabet Med 1995: 12: 142-148.
24. Blanc N, Lucidarme N, Tubiana-Rufi N. [Factors associated with childhood diabetes manifesting as ketoacidosis and its severity]. Arch Pediatr 2003: 10: 320-325.
25. Franzese A, Valerio G, Argenziano A et al. Social deprivation influences illness onset in diabetic children. Diabetologia 1997: 40: 988-989.
26. Svoren B, Hood K, Volkening L et al. Predictors of DKA at onset in pediatric type 1 diabetes. Diabetes 2006; 55 (Suppl. 1): A549.
27. Rodin GM, Daneman D. Eating disorders and IDDM. A problematic association. Diabetes Care 1992: 15: 1402-1412.
28. Skinner TC. Recurrent diabetic ketoacidosis: Causes, prevention and management. Horm Res 2002: 57 (Suppl. 1): 78-80.
29. Morris AD, Boyle DI, McMahon AD, Greene SA, Mac Donald TM, Newton RW. Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus. The DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland. Medicines Monitoring Unit. Lancet 1997: 350: 1505-1510.
30. Hanas R, Ludvigsson J. Hypoglycemia and ketoacidosis with insulin pump therapy in children and adolescents. Pediatr Diabetes 2006: 7 (Suppl. 4): 32-38.
31. Danne T, Battelino T, Jarosz-Chobot P. The PedPump Study: A low percentage of basal insulin and more than five daily boluses are associated with better centralized HbA1c in 1041 children on CSII from 17 countries. Diabetes 2005: 54 (Suppl. 1): A453.
32. Hanas, R, Lindblad B, Lindgren F. A 2-year population study of pediatric ketoacidosis in Sweden: Predisposing conditions and insulin pump use. Diabetes 2005: 54 (Suppl. 1): A455.
33. Vanelli M, Chiari G, Ghizzoni L, Costi G, Giacalone T, Chiarelli F. Effectiveness of a prevention program for diabetic ketoacidosis in children. An 8-year study in schools and private practices. Diabetes Care 1999: 22: 7-9.
34. Bui H, Stein R, Fung K, To T, Daneman D. DKA at diabetes onset may be caused by missed diagnosis especially in children < 3y. Diabetes 2006: 55 (Suppl. 1): A54.
35. Mallare JT, Cordice CC, Ryan BA, Carey DE, Kreitzer PM, Frank GR. Identifying risk factors for the development of diabetic ketoacidosis in new onset type 1 diabetes mellitus. Clin Pediatr (Phila) 2003: 42: 591-597.
36. Diabetes Prevention Trial - Type 1 Diabetes Study Group. Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med 2002; 346: 1685-1691.
37. Mageirsdottir H, Larsen J, Brunborg C, Dahl-Jorgensen K. Nationwide improvement in HBA1c and complication screening in a benchmarking project in childhood diabetes. Pediatr Diabetes 2006: 7: 18.
38. Golden MP, Herrold AJ, Orr DP. An approach to prevention of recurrent diabetic ketoacidosis in the pediatric population. J Pediatr 1985: 107: 195-200.
39. Maldonado MR, D'Amico S, Rodriguez L, Iyer D, B alasubramanyam A. Improved outcomes in indigent patients with ketosis-prone diabetes: effect of a dedicated diabetes treatment unit. Endocr Pract 2003: 9: 26-32.
40. Steindel BS, Roe TR, Costin G, Carlson M, Kaufman FR. Continuous subcutaneous insulin infusion (CSII) in children and adolescents with chronic poorly controlled type 1 diabetes mellitus. Diabetes Res Clin Pract 1995: 27: 199-204.
41. Ellis DA, Frey MA, Naar-King S, Templin T, Cunningham P, Cakan N. Use of multisystemic therapy to improve regimen adherence among adolescents with type 1 diabetes in chronic poor metabolic control: A randomized controlled trial. Diabetes Care 2005: 28: 1604-1610.
42. Ellis DA, Templin T, Naar-King S et al. Multisystemic therapy for adolescents with poorly controlled type I diabetes: Stability of treatment effects in a randomized controlled trial. J Consult Clin Psychol 2007: 75: 168-74.
43. Burdick J, Harris S, Chase P. The importance of ketone testing. Pract Diabetol 2004: 3-11.
44. Laffel L. Ketone bodies: A review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Res Rev 1999: 15: 412-426.
45. Goldstein DE, Little RR, Lorenz RA et al. Tests of glycemia in diabetes. Diabetes Care 2004: 27: 1761-1773.
46. Attia N, Jones TW, Holcombe J, Tamborlane WV. Comparison of human regular and lispro insulins after interruption of continuous subcutaneous insulin infusion and in the treatment of acutely decompensated IDDM. Diabetes Care 1998: 21: 817-821.
47. Guerci B, Meyer L, Salle A et al. Comparison of metabolic deterioration between insulin analog and regular insulin after a 5-hour interruption of a continuous subcutaneous insulin infusion in type 1 diabetic patients. J Clin Endocrinol Metab 1999: 84: 2673-2678.
48. Orsini -Federici M, Akwi JA, Canonico V et al. Early detection of insulin deprivation in continuous subcutaneous insulin infusion-treated patients with type 1 diabetes. Diabetes Technol Ther 2006: 8: 67-75.
49. Matta MP, Melki V, Bessiere-Lacombe S, Hanaire-Broutin H. What are capillary blood ketone levels in type 1 diabetic patients using CSII in normal conditions of insulin delivery? Diabetes Metab 2004: 30: 543-547.
50. Rewers A, McFann K, Chase HP. Bedside monitoring of blood beta-hydroxybutyrate levels in the management of diabetic ketoacidosis in children. Diabetes Technol Ther 2006: 8: 671-676.
51. Bektas F, Eray O, Sari R, Akbas H. Point of care blood ketone testing of diabetic patients in the emergency department. Endocr Res 2004: 30: 395-402.
52. Harris S, Ng R, Syed H, Hillson R. Near patient blood ketone measurements and their utility in predicting diabetic ketoacidosis. Diabet Med 2005: 22: 221-224.
53. Wallace TM, Matthews DR. Recent advances in the monitoring and management of diabetic ketoacidosis. QJM 2004: 97: 773-780.
54. Laffel LM, Wentzell K, Loughlin C, Tovar A, Moltz K, Brink S. Sick day management using blood 3-hydroxybutyrate (3-OHB) compared with urine ketone monitoring reduces hospital visits in young people with T1DM: A randomized clinical trial. Diabet Med 2006: 23: 278-284.
55. Laffel L, Brink S, Kaufman FR, Bergenstal R, Finegold SE, Jenkins M. Frequency of elevation in blood B-hydroxybutyrate (B-OHB) during home monitoring and association with glycemia in insulin-treated children and adults. Diabetes 2000: 49 (Suppl. 1): A92.
56. Levine BS, Anderson BJ, Butler DA, Antisdel JE, Brackett J, Laffel LM. Predictors of glycemic control and short-term adverse outcomes in youth with type 1 diabetes. J Pediatr 2001: 139: 197-203.
57. Brink SJ. Diabetic ketoacidosis. Acta Paediatr 1999: 88 (Suppl.): 14-24.
58. Vanelli M, Chiari G, Capuano C. Cost effectiveness of the direct measurement of 3-beta-hydroxybutyrate in the management of diabetic ketoacidosis in children. Diabetes Care 2003: 26: 959.